In addition to different injuries, infections are the most common reason for giving up training altogether or reducing its volume and intensity, as well as a lack of opportunities to participate in sports competitions. Nowadays, a slow but constant re-emergence of pertussis, especially among teenagers and young adults, including athletes, can be observed. This paper describes an outbreak of pertussis among professional Polish shooters, focusing on the transmission of Bordetella pertussis infection between members of the national team, its influence on performance capacity and adverse event analysis. From 9 June, 2015 to 31 July, 2015, a total of 4 confirmed and suspected cases of pertussis were reported among members of the Polish Sport Shooting National Team, their relatives and acquaintances. Pertussis significantly decreased exercise performance of the first athlete, a 35-year-old woman, interrupted her training, and finally resulted in failure to win a medal or quota place. Pertussis also significantly decreased performance of the second athlete, a 25-year-old shooter. The other cases emerged in their families. Whooping cough is a real threat to athletes and should be prevented. Preventive measures include appropriate immunization, constant medical supervision, as well as early isolation, diagnostic tests and treatment of all infected sport team members. Regular administration of booster doses of the acellular pertussis vaccine (Tdpa) every 5 years seems reasonable. 
INTRODUCTION
The widespread Gram-negative bacterium Bordetella pertussis causes whooping cough or pertussis, an acute, potentially serious infectious disease affecting mainly infants and young children in the pre-vaccine era, currently occurring in healthy teenagers and adults including athletes. In the 20th century, before the availability of pertussis vaccine, whooping cough was one of the major causes of mortality in infants. Universal pertussis immunizations while maintaining a high level of vaccination coverage significantly decreased incidence of the disease in infants and young children. Nowadays, we can observe slow but constant re-emergence of pertussis, especially among teenagers and young adults, including athletes. According to the present Polish Immunization Schedule, the routine pertussis immunization includes administration of 4 doses of diphtheria-tetanus-whole cell pertussis vaccine (Diphtheria-Tetanus Pertussis whole cell vaccine -DTPw) in infants at 2, 4, 6 and 16 to 18 months of age and subsequent administration of two booster doses of diphtheria-tetanus-and led to sleep deprivation, markedly decreasing her sport performance. It resulted in her failure to obtain a Quota Place to enter the Olympic Games. The patient returned home and was referred to a pulmonologist 5 weeks after the onset of symptoms. Serologic tests with high antibody titres to pertussis toxin (IgG concentration higher than 200 IU/ml) confirmed the diagnosis of pertussis (no history of pertussis vaccination during the past 10 years was obtained from the patient). The athlete was prescribed oral azithromycin in a dose of 500 mg/day for one week. The paroxysms of coughing decreased in frequency and finally resolved within the next 3 weeks.
Secondary cases and spread of the Bordetella pertussis infection
Two weeks later, the husband of the index case developed a malaise and cough and his serological tests (IgG concentration higher than 200 IU/ml) confirmed Bordetella pertussis infection. The next secondary case was a 25-year-old male elite shooter, also a member of the Polish National Team, who developed symptoms of nasal congestion, rhinorrhea, sneezing, malaise, fatigue, and dry cough during the European Championships in 2015. One month previously he had travelled together with the index case by the same plane and bus in close proximity. The athlete was given oral azithromycin in a daily dose of 500 mg for one week without waiting for laboratory confirmation of the disease to prevent spreading. The athlete responded well to the empiric therapy, but the dry cough resolved after the next 3 weeks. Serological tests performed a month after the onset of symptoms revealed markedly elevated IgG and IgA titres to pertussis toxin (IgG and IgA concentrations higher than 200 IU/ml and 14 IU/ml, respectively), making the diagnosis of pertussis highly probable. The epidemiologic investigation revealed that the 64-year-old man, a coach of the Spanish National Team, was probably the source of infection for the index case. Although his diagnosis was not confirmed by serological tests, the presentation of the disease with typical paroxysms of coughing persisting for a few months strongly suggested the diagnosis of pertussis.
Adverse event analysis
The described outbreak of pertussis among Polish elite shooters (an appropriate timeline is presented in Figure 1 ) is worth a deeper analysis to prevent similar outbreaks in future. The modern sport is highly competitive, and all factors impairing even slightly the athlete's performance during games reduce the chance of winning. In addition to different injuries, infections are the most common reason for giving up training altogether or reducing its volume and intensity, as well as a lack of opportunities to participate in sports competitions [7] [8] [9] [10] [11] [12] . Since pathogens vary in nature and can be transmitted through different routes -inhalation of airborne infectious agents, skin contact or injuries, ingestion of contaminated food or water, via vectors (e.g. tick or mosquito bites) and sexual contacts -infections can be prevented by various measures including the isolation of infectious subjects, hygienic measures, mosquito avoidance, immunization and pharmacological prophylaxis. Simple hygiene measures performed adults [4] . The epidemiology of pertussis is similar in Europe: the incidence of pertussis is highest in children aged 10-14 years (13.2% of cases in 2014) and adults older than 30 (47.7%) [5] . One should also remember that epidemics occur every 3-5 years in the natural course of the disease. 
Description of the outbreak The index case
The index case was 32-year-old female elite shooter, a member of the Polish National Team. She presented with a paroxysmal dry cough, localized upper abdomen pain, loss of appetite and underperformance at the day of departure for the European Games in 2015. The athlete's disease started two weeks earlier from an isolated, recurrent paroxysmal dry cough not accompanied by other symptoms. Previously, she had been healthy, with no chronic conditions, allergy and negative smoking history. The physical examination did not reveal any abnormalities. Her basic laboratory tests were also unremarkable. Because the chronic cough persisted for approximately 3 weeks, a chest x-ray was performed and revealed no abnormalities. The allergy, asthma and atypical respiratory infections caused by Mycoplasma or Chlamydophila were taken into consideration but the respiratory allergy was regarded as the most probable explanation. The persistent cough also raised a suspicion for Bordetella pertussis infection, but a lack of the classic presentation with a characteristic wheezing was one of the arguments against that diagnosis. Empirical therapy with azithromycin in a single daily dose of 500 mg for 3 days was ordered because serologic and microbiological testing was not available at the sport venue. Clinical symptoms partially resolved, but after a few days the frequency of cough paroxysms increased. The cough did not respond to symptomatic antitussive therapy. The extremely strong coughing exhausted the athlete Biology of Sport, Vol. 34 No3, 2017 245
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by athletes may decrease the risk of infecting themselves or others: washing hands, especially before and after preparing food, before eating, and after using the toilet, avoiding touching mucous membranes (eyes, nose or mouth) with hands, staying home when ill 
Poor surveillance of infectious diseases
Infectious diseases among athletes and other members of sport teams should be detected and reported. Based on the local epidemiology, infectious diseases important for the athletes should be identified and prophylactic measures implemented promptly. In the case of pertussis, vaccination is an effective preventive measure, and all athletes and their family members should regularly obtain booster doses. For contacts, pharmacological prophylaxis should be given (azithromycin, clarithromycin or erythromycin doses and duration of the antibiotic courses are the same for prophylaxis and treatment of the disease) [14] .
Delayed diagnosis
The etiology of the cough in the index case was determined late -too late for effective treatment with antibiotics. Pertussis is contagious for about 3 weeks if untreated, but only for 5 days with a proper antibiotic therapy. The acute disease in the athlete, especially in team sports, must be diagnosed as soon as possible to avoid or minimize the risk of spreading.
Exposure to infected persons
The index case probably contracted the whooping cough through a direct contact with the symptomatic coach. All symptomatic persons should be excluded from any contact with athletes and other team members as well as auxiliary staff.
DISCUSSION
Despite increasing awareness, pertussis is often overlooked in the differential diagnosis of prolonged coughing in adolescents and adults. This is partially due to the fact that its clinical symptoms in adults are frequently scarce and nonspecific. During the initial, catarrhal (prodromal) phase, patients present with a low-grade fever, rhinitis and fatigue. Non-characteristic symptoms are undistinguishable from common colds and usually treated symptomatically. When paroxysms of the dry cough intensify in the night, that is a classic sign of pertussis development, but it is too late for effective antibiotic treatment [15] .
If untreated, paroxysms of coughing can occur for a few weeks, up to three months, then gradually resolve as the patient passes into a convalescent phase. Pertussis should always be taken into consideration as a possible cause of a prolonged cough as adolescents and adults remain a reservoir of infection. It is worth noting that in this age group it can be the only symptom of the disease due to a prior infection or immunization history [16] . Complications of pertussis in athletes may occur as bacterial superinfections (pneumonia, otitis media) but more frequently as repercussions of the severe cough:
FIG. 1. Timeline of pertussis outbreak in Polish shooters (including the intervals between cases and treatment).
As mentioned above, antibiotic treatment in the catarrhal phase of infection may shorten the duration of symptoms. Antibiotics administered in the paroxysmal stage will not have an impact on the clinical course of the disease but can reduce the spread of infection.
First line therapies include azithromycin and other macrolides, but in the case of allergy or intolerance trimethoprim-sulfamethoxazole can also be used [22, 23] . There is no proven symptomatic therapy for severe coughing accompanying pertussis. It resolves spontaneously after a few weeks when respiratory ciliated cells damaged by pertussis toxin are regenerated.
Proper preparation for international competitions such as the Olympic Games needs many years of training and a lot of effort.
Infectious diseases such as pertussis directly affect the general condition of the athlete and his or her sport performance and interrupt preparations or even put an end to participation in a sport event.
Pertussis may significantly decrease sport performance as well as [25] . This is one of the reasons why administration of the next dose to young adults at a 5 to 10 year interval seems to be reasonable [26] , although there is no strong evidence that this approach will be economically or epidemically justified [25] . In such a specific group as athletes, who are exposed to many risk factors of acquiring infectious dis- as reducing the duration of disease symptoms [17] . In the second, paroxysmal phase of pertussis, polymerase chain reaction testing is more sensitive as well as serology. PCR tests can be performed up to 3-4 weeks from the appearance of initial symptoms, and its results are not affected by previous antibiotic treatment [18] . Serologic testing includes measuring titres of specific IgG, IgM and IgA antibodies, mainly to pertussis toxin (PT), and comparing titres from sera taken in the paroxysmal and convalescent phases of infection (2-3 weeks apart). IgG and IgA testing is most specific for diagnosis of Bordetella pertussis infection [19] . The best time to perform serologic tests starts 2 weeks after the onset of symptoms, when antibodies rise in the serum. Diagnosis may be established by a single test with a high IgG anti-PT titre greater than or equal to 100-125 EU/ml or a minimum fourfold rise in antibody titres when the test is performed twice -in the acute phase and the convalescent phase [20] . To eases (common travelling, sharing small spaces such as planes, buses, hotels, changing rooms, training halls, participating in large events) it seems to be beneficial to administer additional doses of Tdpa vaccines at regular intervals [27, 28] . The risk of a clinically relevant disease is around 1:500 per year, and vaccination reduces this risk by over 90%, at least for the first 2-3 years after vaccination [29] .
CONCLUSIONS
Pertussis poses a real risk to the athlete's welfare and optimal performance. Therefore it is reasonable to mitigate this risk with proper anticipatory preventive measures: constant surveillance, early isolation and treatment of infected persons, regularly checking the vaccination status of all team members, and administration of booster doses of Tdpa vaccine every 5-10 years.
